Table: begin end state 1 22 signal peptide 23 210 non-cytoplasmic 211 234 transmembrane 235 240 cytoplasmic 241 260 transmembrane 261 265 non-cytoplasmic 266 286 transmembrane 287 298 cytoplasmic 299 320 transmembrane 321 347 non-cytoplasmic 348 367 transmembrane 368 399 cytoplasmic 400 418 transmembrane 419 430 non-cytoplasmic 431 457 transmembrane 458 464 cytoplasmic 465 484 transmembrane 485 499 non-cytoplasmic
Input: >AO353_13540 MSLYRLFLAIAFVLLPMVAHAGDAEDFVAANPVQQAKLLETWAAQPDPARIELINALQQG QLSVDGEVRILRLNNRLRGLIDTALASHQLLAADTKVRLSAAQQLQKSAKPAQLKFLDQQ LAGEKDPSVHAALSLALANLQLVDADPAVRLAAVRLLGETGDPLARTRLEGLLQPGVEAD ATVHTAAETSLAQVKRKLLIGELLGQAFSGMSLGSILLLAALGLAITFGLLGVINMAHGE MLMLGAYSTYVVQLLFQRFAPQAIEFYPLIALPVAFFVTAGIGMALERTVIRHLYGRPLE TLLATWGISLMLIQLVRLLFGAQNVEVANPAWLSGGIQVLPNLVLPYNRIVIIAFALFVV VLTWLLLNKTRLGLNVRAVTQNRNMAACCGVPTGRVDMLAFGLGSGIAGLGGVALSQVGN VGPDLGQSYIIDSFLVVVLGGVGQLAGSVLAAFGLGIANKILEPQIGAVLGKILILALII LFIQKRPQGLFALKGRVID
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server